Oncorus, Inc.

Oncorus, Inc.verified

ONCR

Price:

$0.1205

Market Cap:

$0

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability ...[Read more]

Industry

Biotechnology

IPO Date

2020-10-02

Stock Exchange

NASDAQ

Ticker

ONCR

The Enterprise Value as of November 2024 (TTM) for Oncorus, Inc. (ONCR) is 42.71M

According to Oncorus, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 42.71M. This represents a change of -1.71% compared to the average of 43.45M of the last 4 quarters.

Oncorus, Inc. (ONCR) Historical Enterprise Value (quarterly & annually)

How has ONCR Enterprise Value performed in the past?

The mean historical Enterprise Value of Oncorus, Inc. over the last ten years is 104.63M. The current 42.71M Enterprise Value has changed 3.98% with respect to the historical average. Over the past ten years (40 quarters), ONCR's Enterprise Value was at its highest in in the December 2020 quarter at 594.31M. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

104.63M

Median

107.88M

Minimum

49.28M

Maximum

154.75M

Oncorus, Inc. (ONCR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oncorus, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 22.35%

Maximum Annual Enterprise Value = 154.75M

Minimum Annual Increase = -41.86%

Minimum Annual Enterprise Value = 49.28M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202249.28M-41.86%
202184.76M-21.43%
2020107.88M-30.29%
2019154.75M22.35%

Oncorus, Inc. (ONCR) Average Enterprise Value

How has ONCR Enterprise Value performed in the past?

The current Enterprise Value of Oncorus, Inc. (ONCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

80.64M

5-year avg

104.63M

10-year avg

104.63M

Oncorus, Inc. (ONCR) Enterprise Value vs. Peers

How is ONCR’s Enterprise Value compared to its peers?

Oncorus, Inc.’s Enterprise Value is less than eFFECTOR Therapeutics, Inc. (0), greater than Apollomics, Inc. (4.74M), greater than Angion Biomedica Corp. (-11494787.00), greater than Sigilon Therapeutics, Inc. (22.43M), greater than Pyxis Oncology, Inc. (42.21M), less than Zura Bio Limited (121.39M), greater than Altamira Therapeutics Ltd. (-9969663.00), greater than Elevation Oncology, Inc. (909.70K), greater than Landos Biopharma, Inc. (18.49M), greater than Apexigen, Inc. (42.62M), greater than Cardio Diagnostics Holdings, Inc. (-5121682.00), greater than null (9.47M),

Build a custom stock screener for Oncorus, Inc. (ONCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncorus, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncorus, Inc. (ONCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncorus, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Oncorus, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Oncorus, Inc. (ONCR)?

What is the 3-year average Enterprise Value for Oncorus, Inc. (ONCR)?

What is the 5-year average Enterprise Value for Oncorus, Inc. (ONCR)?

How does the current Enterprise Value for Oncorus, Inc. (ONCR) compare to its historical average?